- Home
- MMLP vs IMA Comparison
MMLP vs IMA Comparison
Compare MMLP & IMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MMLP
- IMA
- Stock Information
- Founded
- MMLP 2002
- IMA 2019
- Country
- MMLP United States
- IMA United States
- Employees
- MMLP N/A
- IMA N/A
- Industry
- MMLP Oil Refining/Marketing
- IMA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MMLP Energy
- IMA Health Care
- Exchange
- MMLP Nasdaq
- IMA Nasdaq
- Market Cap
- MMLP 97.6M
- IMA 92.2M
- IPO Year
- MMLP 2002
- IMA N/A
- Fundamental
- Price
- MMLP $2.60
- IMA $7.24
- Analyst Decision
- MMLP
- IMA Hold
- Analyst Count
- MMLP 0
- IMA 2
- Target Price
- MMLP N/A
- IMA $16.00
- AVG Volume (30 Days)
- MMLP 14.9K
- IMA 34.8K
- Earning Date
- MMLP 10-15-2025
- IMA 11-12-2025
- Dividend Yield
- MMLP 0.76%
- IMA N/A
- EPS Growth
- MMLP N/A
- IMA N/A
- EPS
- MMLP N/A
- IMA N/A
- Revenue
- MMLP $713,263,000.00
- IMA $800,000.00
- Revenue This Year
- MMLP $4.19
- IMA N/A
- Revenue Next Year
- MMLP N/A
- IMA N/A
- P/E Ratio
- MMLP N/A
- IMA N/A
- Revenue Growth
- MMLP N/A
- IMA N/A
- 52 Week Low
- MMLP $2.49
- IMA $6.90
- 52 Week High
- MMLP $4.02
- IMA $18.00
- Technical
- Relative Strength Index (RSI)
- MMLP 41.85
- IMA N/A
- Support Level
- MMLP $2.55
- IMA N/A
- Resistance Level
- MMLP $2.67
- IMA N/A
- Average True Range (ATR)
- MMLP 0.08
- IMA 0.00
- MACD
- MMLP 0.02
- IMA 0.00
- Stochastic Oscillator
- MMLP 31.58
- IMA 0.00
About MMLP Martin Midstream Partners L.P. Limited Partnership
Martin Midstream Partners LP has a diverse set of operations focused in the United States Gulf Coast region. The company's business lines include terminalling, processing, storage, and packaging services for petroleum products and by-products including the refining of naphthenic crude oil; land and marine transportation services for petroleum products and by-products, chemicals, and specialty products; sulfur and sulfur-based products processing, manufacturing, marketing and distribution; and natural gas liquids marketing, distribution and transportation services. Company operates in four segment Terminalling and storage, Transportation, Sulfur service and Specialty products segment. Majority of the revenue derived from Specialty products segment.
About IMA ImageneBio Inc.
ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases. The company is focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody, for the treatment of atopic dermatitis.